FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Marisa Dolled-Filhart

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Procedures

Anatomy

Phenomena

Fluorescent Antibody Technique

Co-author Network

Publications

TOP 3
Arnab Chakravarti; Ali Choucair; Jason Christiansen; Walter J Curran; Adam P Dicker; Marisa Dolled-Filhart; Mark Gustavson; Tim Lautenschlaeger; Paul Mischel; Annette Molinaro; H Ian Robins; Christopher J Schultz; Meihua Wang; David G Brachman; Markus Bredel; Minesh Mehta
RTOG 0211: a phase 1/2 study of radiation therapy with concurrent gefitinib for newly diagnosed glioblastoma patients.
Antonio Gualberto; Marisa Dolled-Filhart; Mark Gustavson; Jason Christiansen; Yu-Fen Wang; Mary L Hixon; Jennifer Reynolds; Sandra McDonald; Agnes Ang; David L Rimm; Corey J Langer; Johnetta Blakely; Linda L Garland; Luis G Paz-Ares; Daniel D Karp; Adrian V Lee
Molecular analysis of non-small cell lung cancer identifies subsets with different sensitivity to insulin-like growth factor I receptor inhibition.
Marisa Dolled-Filhart; Mark Gustavson; Robert L Camp; David L Rimm; John L Tonkinson; Jason Christiansen
Automated analysis of tissue microarrays.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Marisa Dolled-Filhart (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Arnab Chakravarti; Ali Choucair; Jason Christiansen; Walter J Curran; Adam P Dicker; Marisa Dolled-Filhart; Mark Gustavson; Tim Lautenschlaeger; Paul Mischel; Annette Molinaro; H Ian Robins; Christopher J Schultz; Meihua Wang; David G Brachman; Markus Bredel; Minesh Mehta
RTOG 0211: a phase 1/2 study of radiation therapy with concurrent gefitinib for newly diagnosed glioblastoma patients.
International journal of radiation oncology, biology, physics 2013;85(5):1206-11.
2010: Antonio Gualberto; Marisa Dolled-Filhart; Mark Gustavson; Jason Christiansen; Yu-Fen Wang; Mary L Hixon; Jennifer Reynolds; Sandra McDonald; Agnes Ang; David L Rimm; Corey J Langer; Johnetta Blakely; Linda L Garland; Luis G Paz-Ares; Daniel D Karp; Adrian V Lee
Molecular analysis of non-small cell lung cancer identifies subsets with different sensitivity to insulin-like growth factor I receptor inhibition.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(18):4654-65.
2010: Marisa Dolled-Filhart; Mark Gustavson; Robert L Camp; David L Rimm; John L Tonkinson; Jason Christiansen
Automated analysis of tissue microarrays.
Methods in molecular biology (Clifton, N.J.) 2010;664():151-62.
2009: You-Wei Zhang; John Brognard; Chris Coughlin; Zhongsheng You; Marisa Dolled-Filhart; Aaron S. Aslanian; Gerard Manning; Robert T Abraham; Tony Hunter
The F box protein Fbx6 regulates Chk1 stability and cellular sensitivity to replication stress.
Molecular cell 2009;35(4):442-53.
2009: John W Emerson; Marisa Dolled-Filhart; Lyndsay Harris; David L Rimm; David Tuck
Quantitative assessment of tissue biomarkers and construction of a model to predict outcome in breast cancer using multiple imputation.
Cancer informatics 2009;7():29-40.
2006: Marisa Dolled-Filhart; Lisa Rydén; Melissa Cregger; Karin Jirström; Malini Harigopal; Robert L Camp; David L Rimm
Classification of breast cancer using genetic algorithms and tissue microarrays.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(21):6459-68.
2006: Marisa Dolled-Filhart; Anthony McCabe; Jennifer Giltnane; Melissa Cregger; Robert L Camp; David L Rimm
Quantitative in situ analysis of beta-catenin expression in breast cancer shows decreased expression is associated with poor outcome.
Cancer research 2006;66(10):5487-94.
2005: Anthony McCabe; Marisa Dolled-Filhart; Robert L Camp; David L Rimm
Automated quantitative analysis (AQUA) of in situ protein expression, antibody concentration, and prognosis.
Journal of the National Cancer Institute 2005;97(24):1808-15.
2004: Kyle A DiVito; Aaron J Berger; Robert L Camp; Marisa Dolled-Filhart; David L Rimm; Harriet M Kluger
Automated quantitative analysis of tissue microarrays reveals an association between high Bcl-2 expression and improved outcome in melanoma.
Cancer research 2004;64(23):8773-7.
2004: Robert L Camp; Marisa Dolled-Filhart; David L Rimm
X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(21):7252-9.
2004: Gina G Chung; Maciej P Zerkowski; Idris Tolgay Ocal; Marisa Dolled-Filhart; Jung Y Kang; Amanda Psyrri; Robert L Camp; David L Rimm
beta-Catenin and p53 analyses of a breast carcinoma tissue microarray.
Cancer 2004;100(10):2084-92.
2004: Harriet M Kluger; Marisa Dolled-Filhart; Sofya Rodov; Barry M Kacinski; Robert L Camp; David L Rimm
Macrophage colony-stimulating factor-1 receptor expression is associated with poor outcome in breast cancer by large cohort tissue microarray analysis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(1 Pt 1):173-7.
2003: Idris Tolgay Ocal; Marisa Dolled-Filhart; Thomas G D'Aquila; Robert L Camp; David L Rimm
Tissue microarray-based studies of patients with lymph node negative breast carcinoma show that met expression is associated with worse outcome but is not correlated with epidermal growth factor family receptors.
Cancer 2003;97(8):1841-8.
2003: Robert L Camp; Marisa Dolled-Filhart; Bonnie L King; David L Rimm
Quantitative analysis of breast cancer tissue microarrays shows that both high and normal levels of HER2 expression are associated with poor outcome.
Cancer research 2003;63(7):1445-8.
2003: Jung Y Kang; Marisa Dolled-Filhart; Idris Tolgay Ocal; Baljit Singh; Chen-Yong Lin; Robert B Dickson; David L Rimm; Robert L Camp
Tissue microarray analysis of hepatocyte growth factor/Met pathway components reveals a role for Met, matriptase, and hepatocyte growth factor activator inhibitor 1 in the progression of node-negative breast cancer.
Cancer research 2003;63(5):1101-5.
2003: Marisa Dolled-Filhart; Robert L Camp; Diane Kowalski; Bradley L Smith; David L Rimm
Tissue microarray analysis of signal transducers and activators of transcription 3 (Stat3) and phospho-Stat3 (Tyr705) in node-negative breast cancer shows nuclear localization is associated with a better prognosis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(2):594-600.
2001: Jiang Qian; Marisa Dolled-Filhart; J Lin; H Yu; Mark Gerstein
Beyond synexpression relationships: local clustering of time-shifted and inverted gene expression profiles identifies new, biologically relevant interactions.
Journal of molecular biology 2001;314(5):1053-66.